U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions caused by COVID-19
Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds
Date:
U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions caused by COVID-19
Popular
© 2024 ECCO BUZZER. All Rights Reserved. Created by Go Hype Media.